Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Destiny Pharma plc (GB:DEST)
LSE:DEST
Destiny Pharma plc (DEST) Share Price & Analysis
6 Followers
DEST Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range15.55p - 84.00p
Previous Close23p
Volume715.70K
Average Volume (3M)453.19K
Market Cap
£21.92M
Enterprise Value17.02M
Total Cash (Recent Filing)£4.90M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)-3.3
Beta0.97
Next Earnings
Apr 25, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding95,271,863
10 Day Avg. Volume105,846
30 Day Avg. Volume453,191
Standard Deviation0.23
R-Squared0.00213
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)2.11
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Destiny Pharma plc News
PremiumCompany Announcements
Destiny Pharma Advances XF-73, Strikes Sebela DealOptions Prices
Currently, No data available
---
Ownership Overview
8.71% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
91.29% Public Companies and
Individual Investors
DEST FAQ
What was Destiny Pharma plc’s price range in the past 12 months?
Destiny Pharma plc lowest share price was 15.55p and its highest was 84.00p in the past 12 months.
What is Destiny Pharma plc’s market cap?
Currently, no data Available
When is Destiny Pharma plc’s upcoming earnings report date?
Destiny Pharma plc’s upcoming earnings report date is Apr 25, 2024 which is 3 days ago.
How were Destiny Pharma plc’s earnings last quarter?
Destiny Pharma plc released its earnings results on Sep 20, 2023. The company reported -0.031p earnings per share for the quarter, missing the consensus estimate of N/A by -0.031p.
Is Destiny Pharma plc overvalued?
According to Wall Street analysts Destiny Pharma plc’s price is currently Overvalued.
Does Destiny Pharma plc pay dividends?
Destiny Pharma plc does not currently pay dividends.
What is Destiny Pharma plc’s EPS estimate?
Destiny Pharma plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Destiny Pharma plc have?
Destiny Pharma plc has 95,311,870 shares outstanding.
What happened to Destiny Pharma plc’s price movement after its last earnings report?
Destiny Pharma plc reported an EPS of -0.031p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.018%.
Which hedge fund is a major shareholder of Destiny Pharma plc?
Currently, no hedge funds are holding shares in GB:DEST
---
Destiny Pharma plc Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Destiny Pharma plc
Destiny Pharma PLC is a clinical-stage biotechnology company which is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. It is involved in developing XF-73 Dermal for the treatment of skin infections of antibiotic-resistant bacteria, XF-73 Nasal for prevention of post-surgical staphylococcal infection, XF Throat for prevention of staphylococcal hospital/ventilator-associated pneumonia infection.
---
Technical Analysis
---